Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0526 Transporter Info
Gene Name	SCN1A
Transporter Name	Voltage-gated sodium channel alpha Nav1.1
Gene ID	6323
UniProt ID	P35498

Post-Translational Modification of This DT
Overview of SCN1A Modification Sites with Functional and Structural Information
Sequence	M E Q T V L V P P G P D S F N F F T R E S L A A I E R R I A E E K A K N P K P D K K D D D E N G P K P N S D L E A G K N L P F I Y G D I P P E M V S E P L E D L D P Y Y I N K K T F I V L N K G K A I F R F S A T S A L Y I L T P F N P L R K I A I K I L V H S L F S M L I M C T I L T N C V F M T M S N P P D W T K N V E Y T F T G I Y T F E S L I K I I A R G F C L E D F T F L R D P W N W L D F T V I T F A Y V T E F V D L G N V S A L R T F R V L R A L K T I S V I P G L K T I V G A L I Q S V K K L S D V M I L T V F C L S V F A L I G L Q L F M G N L R N K C I Q W P P T N A S L E E H S I E K N I T V N Y N G T L I N E T V F E F D W K S Y I Q D S R Y H Y F L E G F L D A L L C G N S S D A G Q C P E G Y M C V K A G R N P N Y G Y T S F D T F S W A F L S L F R L M T Q D F W E N L Y Q L T L R A A G K T Y M I F F V L V I F L G S F Y L I N L I L A V V A M A Y E E Q N Q A T L E E A E Q K E A E F Q Q M I E Q L K K Q Q E A A Q Q A A T A T A S E H S R E P S A A G R L S D S S S E A S K L S S K S A K E R R N R R K K R K Q K E Q S G G E E K D E D E F Q K S E S E D S I R R K G F R F S I E G N R L T Y E K R Y S S P H Q S L L S I R G S L F S P R R N S R T S L F S F R G R A K D V G S E N D F A D D E H S T F E D N E S R R D S L F V P R R H G E R R N S N L S Q T S R S S R M L A V F P A N G K M H S T V D C N G V V S L V G G P S V P T S P V G Q L L P E V I I D K P A T D D N G T T T E T E M R K R R S S S F H V S M D F L E D P S Q R Q R A M S I A S I L T N T V E E L E E S R Q K C P P C W Y K F S N I F L I W D C S P Y W L K V K H V V N L V V M D P F V D L A I T I C I V L N T L F M A M E H Y P M T D H F N N V L T V G N L V F T G I F T A E M F L K I I A M D P Y Y Y F Q E G W N I F D G F I V T L S L V E L G L A N V E G L S V L R S F R L L R V F K L A K S W P T L N M L I K I I G N S V G A L G N L T L V L A I I V F I F A V V G M Q L F G K S Y K D C V C K I A S D C Q L P R W H M N D F F H S F L I V F R V L C G E W I E T M W D C M E V A G Q A M C L T V F M M V M V I G N L V V L N L F L A L L L S S F S A D N L A A T D D D N E M N N L Q I A V D R M H K G V A Y V K R K I Y E F I Q Q S F I R K Q K I L D E I K P L D D L N N K K D S C M S N H T A E I G K D L D Y L K D V N G T T S G I G T G S S V E K Y I I D E S D Y M S F I N N P S L T V T V P I A V G E S D F E N L N T E D F S S E S D L E E S K E K L N E S S S S S E G S T V D I G A P V E E Q P V V E P E E T L E P E A C F T E G C V Q R F K C C Q I N V E E G R G K Q W W N L R R T C F R I V E H N W F E T F I V F M I L L S S G A L A F E D I Y I D Q R K T I K T M L E Y A D K V F T Y I F I L E M L L K W V A Y G Y Q T Y F T N A W C W L D F L I V D V S L V S L T A N A L G Y S E L G A I K S L R T L R A L R P L R A L S R F E G M R V V V N A L L G A I P S I M N V L L V C L I F W L I F S I M G V N L F A G K F Y H C I N T T T G D R F D I E D V N N H T D C L K L I E R N E T A R W K N V K V N F D N V G F G Y L S L L Q V A T F K G W M D I M Y A A V D S R N V E L Q P K Y E E S L Y M Y L Y F V I F I I F G S F F T L N L F I G V I I D N F N Q Q K K K F G G Q D I F M T E E Q K K Y Y N A M K K L G S K K P Q K P I P R P G N K F Q G M V F D F V T R Q V F D I S I M I L I C L N M V T M M V E T D D Q S E Y V T T I L S R I N L V F I V L F T G E C V L K L I S L R H Y Y F T I G W N I F D F V V V I L S I V G M F L A E L I E K Y F V S P T L F R V I R L A R I G R I L R L I K G A K G I R T L L F A L M M S L P A L F N I G L L L F L V M F I Y A I F G M S N F A Y V K R E V G I D D M F N F E T F G N S M I C L F Q I T T S A G W D G L L A P I L N S K P P D C D P N K V N P G S S V K G D C G N P S V G I F F F V S Y I I I S F L V V V N M Y I A V I L E N F S V A T E E S A E P L S E D D F E M F Y E V W E K F D P D A T Q F M E F E K L S Q F A A A L E P P L N L P Q P N K L Q L I A M D L P M V S G D R I H C L D I L F A F T K R V L G E S G E M D A L R I Q M E E R F M A S N P S K V S Y Q P I T T T L K R K Q E E V S A V I I Q R A Y R R H L L K R T V K Q A S F T Y N K N K I K G G A N L L I K E D M I I D R I N E N S I T E K T D L T M S T A A C P P S Y D R V T K P I V E K H E Q E G K D E K A K G K
PTM type	X-Acetylation X-Methylation X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1506
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN1A Lysine 1506 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1936
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN1A Lysine 1936 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN1A			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1946
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN1A Lysine 1946 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN1A			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	1948
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SCN1A Lysine 1948 has the potential to affect its expression or activity.
Methylation
Arginine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Arginine	Modified Location	563
Related Enzyme	Protein arginine N-methyltransferase 1 (PRMT1)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SCN1A Arginine 563 have been reported to have the potential to influence its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Arginine	Modified Location	570
Related Enzyme	Protein arginine N-methyltransferase 1 (PRMT1)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SCN1A Arginine 570 have been reported to have the potential to influence its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Arginine	Modified Location	574
Related Enzyme	Protein arginine N-methyltransferase 1 (PRMT1)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SCN1A Arginine 574 have been reported to have the potential to influence its expression or activity.
N-glycosylation
Asparagine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	211
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 211 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	284
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 284 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	295
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 295 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	301
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 301 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	306
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 306 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	338
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 338 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1378
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 1378 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1392
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 1392 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SCN1A			[6]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	1403
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SCN1A Asparagine 1403 has the potential to affect its expression or activity.
Oxidation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[7]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	179
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SCN1A Cystine 179 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[7]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1982
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SCN1A Cystine 1982 has the potential to affect its expression or activity.
Phosphorylation
Arginine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[8]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	693
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Arginine 693 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[8]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	710
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Arginine 710 has the potential to affect its expression or activity.
Serine	27 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Slowing the inactivation of sodium channels and reducing peak sodium currents			[9]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	1516
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 1516 have been reported to slow the inactivation of sodium channels and reducing peak sodium currents.
PTM Phenomenon 2	Have the potential to influence SCN1A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	169
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 169 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	316
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 316 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	321
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 321 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN1A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	374
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 374 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN1A			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	474
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 474 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN1A			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	480
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 480 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN1A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	482
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 482 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SCN1A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	483
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 483 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SCN1A			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	487
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 487 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SCN1A			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	490
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 490 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SCN1A			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	491
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 491 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SCN1A			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	510
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 510 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SCN1A			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	523
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 523 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SCN1A			[14] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	550
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 550 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SCN1A			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	551
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 551 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SCN1A			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	555
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 555 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence SCN1A			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	558
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 558 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence SCN1A			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	562
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 562 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence SCN1A			[8] , [17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	565
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 565 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence SCN1A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	576
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 576 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence SCN1A			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	718
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 718 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence SCN1A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	856
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 856 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence SCN1A			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1037
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 1037 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence SCN1A			[20]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1566
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 1566 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence SCN1A			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1631
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 1631 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence SCN1A			[22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1918
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Serine 1918 has the potential to affect its expression or activity.
Threonine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	297
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 297 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	303
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 303 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 308 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN1A			[16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	544
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 544 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN1A			[8] , [18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	721
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 721 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN1A			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	723
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 723 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN1A			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1562
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 1562 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN1A			[21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1633
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Threonine 1633 has the potential to affect its expression or activity.
Tyrosine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Increasing SCN1A expression at the cell surface			[5]
Role of PTM	Surface Expression Modulation
Affected Drug/Substrate	Sodium	Results for Drug	Increasing the transport of sodium
Modified Residue	Tyrosine	Modified Location	1495
Related Enzyme	Tyrosine-protein kinase Fyn (FYN)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 1495 have been reported to increase its expression at the cell surface.
PTM Phenomenon 2	Impairing the function of SCN1A			[5]
Role of PTM	Trafficking to Plasma Membrane
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Tyrosine	Modified Location	1498
Related Enzyme	Tyrosine-protein kinase Fyn (FYN)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 1498 have been reported to impaire its transport function.
PTM Phenomenon 3	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Tyrosine	Modified Location	66
Related Enzyme	Tyrosine-protein kinase Fyn (FYN)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 66 have been reported to have the potential to influence its expression or activity.
PTM Phenomenon 4	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	300
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 300 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SCN1A			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	317
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 317 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SCN1A			[16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	545
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 545 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SCN1A			[16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 549 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Tyrosine	Modified Location	1497
Related Enzyme	Tyrosine-protein kinase Fyn (FYN)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 1497 have been reported to have the potential to influence its expression or activity.
PTM Phenomenon 9	Have the potential to influence SCN1A			[23] , [24]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1507
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 1507 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SCN1A			[23] , [25]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1508
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 1508 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Affecting the inward transport of sodium
Modified Residue	Tyrosine	Modified Location	1893
Related Enzyme	Tyrosine-protein kinase Fyn (FYN)
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SCN1A Tyrosine 1893 have been reported to have the potential to influence its expression or activity.
Ubiquitination
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SCN1A			[5]
Role of PTM	Potential impacts
Affected Drug/Substrate	Sodium	Results for Drug	Decreasing the transport of sodium
Modified Residue	Lysine
Related Enzyme	E3 ubiquitin-protein ligase NEDD4-like (NEDD4L)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SCN1A Lysine have been reported to has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SCN1A			[26]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	225
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SCN1A Lysine 225 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SCN1A			[27]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	453
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SCN1A Lysine 453 has the potential to affect its expression or activity.

References
1	Noradrenaline-Specific, Efficient Visualization in Brain Tissue Triggered by Unique Cascade Nucleophilic Substitution. Anal Chem. 2019 Feb 5;91(3):2255-2259.
2	Syntheses, characterization, and ethylene polymerization of titanium and zirconium complexes with [N, O] ligands. Dalton Trans. 2009 Nov 7;(41):8838-45.
3	Vanadium-based imido-alkoxide pro-catalysts bearing bisphenolate ligands for ethylene and epsilon-caprolactone polymerisation. Dalton Trans. 2009 Nov 7;(41):8911-22.
4	Effects of veratridine on Na and Ca currents in frog skeletal muscle. Gen Pharmacol. 1994 Dec;25(8):1661-6.
5	An update on transcriptional and post-translational regulation of brain voltage-gated sodium channels. Amino Acids. 2016 Mar;48(3):641-651.
6	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: SCN1A_HUMAN)
7	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
8	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
9	UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. (ID: P35498)
10	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
11	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
12	Global phosphoproteomics of activated B cells using complementary metal ion functionalized soluble nanopolymers. Anal Chem. 2014 Jul 1;86(13):6363-71.
13	Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics. 2013 Oct 8;91:286-96.
14	Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics. 2015 Jan;15(2-3):500-7.
15	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
16	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
17	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
18	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
19	Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis. Anal Chem. 2015 Nov 3;87(21):10995-1006.
20	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
21	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
22	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
23	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
24	Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, S rc- r elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal M yristoylation S ites (SRMS). Mol Cell Proteomics. 2018 May;17(5):925-947.
25	Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ Res. 2005 May 13;96(9):991-8.
26	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
27	Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease. Proteomics. 2018 Oct;18(20):e1800108.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence